Back
Robinhood Markets Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
99
HOOD
Robinhood Markets
Last Price:
$64.91
Seasonality Move:
11.56%
Sell
42
APLS
Apellis Pharmaceuticals
Last Price:
$18.53
Seasonality Move:
5.74%
Buy
99
Robinhood Markets (HOOD)
is a Buy
Is Robinhood Markets a Buy, Sell or Hold?
-
The current Robinhood Markets [HOOD] share price is $64.91. The Score for HOOD is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
-
HOOD is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $18.51. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HOOD Stock Price Chart
What is Robinhood Markets's stock price today?
-
The Robinhood Markets share price today is $64.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HOOD is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $18.51The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
HOOD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.15 | Buy |
| Relative Strength Index (14 RSI): | 75.45 | Buy |
| Chaikin Money Flow: | 19318593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.78 | Sell |
| Relative Strength Index (14 RSI): | 48.87 | Sell |
| Chaikin Money Flow: | 1017688 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.12 - 19.1) | Buy |
| Bollinger Bands (100): | (19.64 - 30.18) | Sell |
HOOD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.96 | Buy |
| 20-day SMA: | 53.67 | Buy |
| 50-day SMA: | 46.22 | Buy |
| 200-day SMA: | 37.17 | Buy |
| 8-day EMA: | 60.68 | Buy |
| 20-day EMA: | 55.01 | Buy |
| 50-day EMA: | 49.68 | Buy |
| 200-day EMA: | 39.27 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.35 | Buy |
| 20-day SMA: | 18.1 | Buy |
| 50-day SMA: | 20.42 | Sell |
| 200-day SMA: | 28.85 | Sell |
| 8-day EMA: | 17.7 | Buy |
| 20-day EMA: | 18.21 | Buy |
| 50-day EMA: | 20.42 | Sell |
| 200-day EMA: | 29 | Sell |
Robinhood Markets Earnings Growth & HOOD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.08 per share, an increase this year of $0.19 per share, and an increase next year of $0.25 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Robinhood Markets Technical Analysis
| May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||